Skip to main content
Kane Biotech Inc. logo

Kane Biotech Inc. — Investor Relations & Filings

Ticker · KNE ISIN · CA4838092084 TSXV Manufacturing
Filings indexed 218 across all filing types
Latest filing 2024-04-22 Regulatory Filings
Country CA Canada
Listing TSXV KNE

About Kane Biotech Inc.

https://kanebiotech.com/

Kane Biotech Inc. is a biotechnology company engaged in the research, development, and commercialization of proprietary technologies designed to prevent and remove microbial biofilms, which are a major contributor to chronic infections and impaired healing. The company holds extensive intellectual property related to biofilm formation and dispersal mechanisms, utilizing proprietary technologies such as DispersinB® and coactiv+®. Its primary commercial focus is advanced wound care, where products like the revyve® Antimicrobial Wound Gel and Spray are designed to disrupt biofilms and promote healing. The product pipeline also includes surgical and dermatological applications for both human and animal health.

Recent filings

Filing Released Lang Actions
Material change report - English.pdf
Regulatory Filings
2024-04-22 English
News release - English.pdf
Regulatory Filings
2024-04-15 English
52-109FV1 - Certification of annual filings - CEO (E).pdf
Regulatory Filings
2024-03-26 English
52-109FV1 - Certification of annual filings - CFO (E).pdf
Regulatory Filings
2024-03-26 English
Annual MD&A - English.pdf
Regulatory Filings
2024-03-26 English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF
Regulatory Filings
2024-03-26 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.